Alloreactive t cells and cytokines in murine graft versus host disease 5

The mixed epidermal cell lymphocyte-reaction is the most predictive factor of acute graft-versus-host disease in bone marrow graft recipients.. Prediction by a modified mixed leukocyte

CHAPTER 5 REFERENCES

Adema GJ, Hartgers F, Verstraten R, de Vries E, Marland G, Menon S, Foster

J, Xu Y, Nooyen P, McClanahan T, Bacon KB, Figdor CG 1997 A

dendritic-cell-derived C-C chemokine that preferentially attracts naive T cells Nature 387(6634):

713-717

Allen RD, Staley TA and Sidman CL 1993 Differential cytokine expression in

acute and chronic murine graft-versus-host disease Eur J Immunol 23: 333-337

Altman JD, Moss PA, Goulder PJ, Barouch DH, McHeyzer-Williams MG, Bell

JI, McMichael AJ, Davis MM 1996 Phenotypic analysis of antigen-specific T

Anasetti C, Howe C, Petersdorf EW, Martin PJ, Hansen JA 1994 Marrow

transplants from HLA matched unrelated donors: an NMDP update and the Seattle experience.Bone Marrow Transplant 13(6): 693-695

Angulo R and Fulcher DA 1998 Measurement of Candida-specific blastogenesis:

Comparison of carboxyfluorescein succinimidyl ester labelling of T cells, thymidine

incorporation, and CD69 expression Cytometry 34:143

Annacker O, Pimenta-Araujo R, Burlen-Defranoux O, Barbosa TC, Cumano A, Bandeira A 2001 CD25+ CD4+ T cells regulate the expansion of peripheral CD4 T

cells through the production of IL-10 J Immunol 166: 3008 –3018

Armitage JO 1994 Bone marrow transplantation N Engl J Med 330: 827-838

Arnold D, Wasem C, Juillard P, Graber P, Cima I, Frutschi C, Herren S, Jakob

S, Alouani S, Mueller C, Chvatchko Y, Brunner T 2002 IL-18-independent

cytotoxic T lymphocyte activation and IFN-gamma production during experimental

acute graft-versus-host disease Int Immunol 14(5): 503-511

Asano M, Toda M, Sakaguchi N, Sakaguchi S 1996 Autoimmune disease as a

consequence of developmental abnormality of a T cell subpopulation J Exp Med

184: 387 –396

Asseman C, Mauze S, Leach MW, Coffman RL, Powrie F 1999 An essential role

for interleukin 10 in the function of regulatory T cells that inhibit intestinal

inflammation J Exp Med 190(7): 995-1004

Austrup F, Vestweber D, Borges E, Lohning M, Brauer R, Herz U, Renz H, Hallmann R, Scheffold A, Radbruch A, Hamann A 1997 P- and E-selectin

mediate recruitment of T-helper-1 but not T-helper-2 cells into inflammed tissues

Nature 385(6611): 81-83

Aususel FM, Brent R, Kingston RE, Moore D Preparation of cytoplasmic RNA

from tissue culture cells Current Protocols in Molecular Biology Wiley and Sons,

Singapore Unit 4.1.5 (Supplement 1)

Aversa F, Tabilio A, Terenzi A, Velardi A, Falzetti F, Giannoni C, Iacucci R, Zei

T, Martelli MP, Gambelunghe C 1994 Successful engraftment of T-cell-depleted

haploidentical "three-loci" incompatible transplants in leukemia patients by addition

of recombinant human granulocyte colony-stimulating factor-mobilized peripheral

blood progenitor cells to bone marrow inoculum Blood 84(11): 3948-3955

Baba M, Imai T, Nishimura M, Kakizaki M, Takagi S, Hieshima K, Nomiyama

H, Yoshie O 1997 Identification of CCR6, the specific receptor for a novel

lymphocyte-directed CC chemokine LARC.J Biol Chem 272(23): 14893-14898

Baccarini M, Schwinzer R, Lohmann-Matthes ML 1989 Effect of human

recombinant IL-2 on murine macrophage precursors Involvement of a receptor

distinct from the p55 (Tac) protein J Immunol 142:118-125

Baecher-Allan C, Brown JA, Freeman GJ, Hafler DA 2001 CD4+CD25

regulatory T cells in human peripheral blood J Immunol 167: 1245 –1253

Baecher-Allan C, Viglietta V and Hafler DA 2002 Inhibition of human

CD4+CD25+ high regulatory T cell function J Immunol 169: 6210 –6217

Baggiolini M 1998 Chemokines and leukocyte traffic Nature 392: 565-568

Bagot M, Cordonnier C, Tilkin AF, Heslan M, Vernant JP, Dubertret L, Levy

JP 1986 A possible predictive test for graft-versus-host disease in bone marrow graft

recipients: the mixed-epidermal cell-lymphocyte reaction Transplantation 41(3):

316-319

Bagot M, Mary JY, Heslan M, Kuentz M, Cordonnier C, Vernant JP, Dubertret

L, Levy JP 1988 The mixed epidermal cell lymphocyte-reaction is the most

predictive factor of acute graft-versus-host disease in bone marrow graft recipients Br

J Haematol 70(4): 403-409

Bargatze RF, Butcher EC 1993 Rapid G protein-regulated activation event

involved in lymphocyte binding to high endothelial venules J Exp Med 178(1):

367-372

Barrat FJ, Cua DJ and Boonstra A 2002 In vitro generation of interleukin

10-producing regulatory CD4+ T Cells is induced by immunosuppressive drugs and

inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines J Exp Med 195: 603

–616

Barrett AJ 1989 Graft versus host disease clinical features and biology Bone

Marrow Transplant 4 Suppl 4: 18-21

Barrett AJ 1997 Mechanisms of the graft-versus-leukemia reaction Stem Cells 15:

248-258

Batra JK, FitzGerald DJ, Chaudhary VK, Pastan I 1991 Single-chain

immunotoxins directed at the human transferrin receptor containing Pseudomonas

exotoxin A or diphtheria toxin: anti-TFR(Fv)-PE40 and DT388-anti- TFR(Fv) Mol

Cell Biol 11, 2200

Bell EB, Sparshott SM, Drayson MT, Ford WL 1987 The stable and permanent

expansion of functional T lymphocytes in athymic nude rats after a single injection of

mature T cells J Immunol 139: 1379-1384

Belperio JA, Burdick MD, Keane MP, Xue YY, Lynch JP 3rd, Daugherty BL, Kunkel SL, Strieter RM 2000 The role of the CC chemokine, RANTES, in acute

lung allograft rejection.J Immunol 165(1): 461-472

Berg EL, Yoshino T, Rott LS, Robinson MK, Warnock RA, Kishimoto TK, Picker LJ, Butcher EC 1991 The cutaneous lymphocyte antigen is a skin

lymphocyte homing receptor for the vascular lectin endothelial cell-leukocyte adhesion molecule 1 J Exp Med 174(6): 1461-1466

Bishara A, Brautbar C, Nagler A, Slavin S, Leshem B, Cohen I, Kedar E 1994

Prediction by a modified mixed leukocyte reaction assay of graft-versus-host disease and graft rejection after allogeneic bone marrow transplantation Transplantation

57(10): 1474-1479

Bishop DK and Orosz CG 1989 Limiting dilution analysis for alloreactive,

TCGF-secretory T cells: two related LDA methods that discriminate between unstimulated

precursor T cells and in vivo-alloactivated T cells Transplantation 47: 671-677

Bjorkman PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL, Wiley DC

1987 The foreign antigen binding site and T cell recognition regions of class I

histocompatibility antigens.Nature 329(6139): 512-518

Bleul CC, Schultze JL and Springer TA 1998 B lymphocyte chemotaxis regulated

in association with microanatomic localization, differentiation state, and B cell receptor engagement.J Exp Med 187(5): 753-762

Bleul CC, Wu L, Hoxie JA, Springer TA, Mackay CR 1997 The HIV coreceptors

CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes Proc Natl Acad Sci U S A 94(5): 1925-1930

Boehm U, Klamp T, Groot M, Howard JC 1997 Cellular responses to

interferon-gamma Annu Rev Immunol 15: 749-795 Review

Boltard C, Tinsil J, Assan R, Mogenet A, Debussche X and Bach JF 1992

Treatment of type I diabetesmellitus with DAB486-IL-2, a toxin conjugate with targets activated T-lymphocytes Proceedings of the European Association for Study

of Diabetes, A218 (Abstract)

Bonecchi R, Bianchi G, Bordignon PP, D'Ambrosio D, Lang R, Borsatti A, Sozzani S, Allavena P, Gray PA, Mantovani A, Sinigaglia F 1998 Differential

expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s.J Exp Med 187(1): 129-134

Borges E, Tietz W, Steegmaier M, Moll T, Hallmann R, Hamann A, Vestweber

D 1997 P-selectin glycoprotein ligand-1 (PSGL-1) on T helper 1 but not on T helper

2 cells binds to P-selectin and supports migration into inflamed skin J Exp Med

185(3): 573-578

Bouma GJ, van der Meer-prins EM, van der Woude FJ, van Rood JJ, Claas FH

1995 Relevance of pretransplant donor-specific T cell allorepertoire for human

kidney graft survival Transplantation 59: 969-976

Bowers WE 1974 Graft-versus-host and cytotoxic activity of rat thoracic duct

lymphocytes fractionated by zonal centrifugation after culture on allogeneic

fibroblasts J Immunol 113(4): 1252-1261

Bradley LM and Watson SR 1996 Lymphocyte migration into tissue: the paradigm

derived from CD4 subsets.Curr Opin Immunol 8(3): 312-320

prevents graft-versus-host disease after allogeneic bone marrow transplantation in

Bunjes D, Theobald M, Nierle T, Arnold R, Heimpel H 1995b Presence of

host-specific interleukin 2-secreting T helper cell precursors correlates closely with active primary and secondary chronic graft-versus-host disease Bone Marrow Transplant

15(5): 727-732

Burgstahler R, Kempkes B, Steube K, Lipp M 1995 Expression of the chemokine

receptor BLR2/EBI1 is specifically transactivated by Epstein-Barr virus nuclear antigen 2.Biochem Biophys Res Commun 215(2): 737-743

Butcher EC and Picker LJ 1996 Lymphocyte homing and homeostasis Science

Campbell JJ, Hedrick J, Zlotnik A, Siani MA, Thompson DA, Butcher EC 1998

Chemokines and the arrest of lymphocytes rolling under flow conditions Science

279(5349): 381-384

Cantrell DA and Smith KA 1983 Transient expression of interleukin 2 receptors

Consequences for T cell growth J Exp Med 158: 1895-1911

Caramalho I, Lopes-Carvalho T, Ostler D, Zelenay S, Haury M, Demengeot J

2003 Regulatory T cells selectively express toll-like receptors and are activated by

lipopolysaccharide J Exp Med 197: 403 –411

Cavazzana-Calvo M, Fromont C, Le Deist F, Lusardi M, Coulombel L, Derocq

JM, Gerota I, Griscelli C, Fischer A 1990 Specific elimination of alloreactive T

cells by an anti-interleukin-2 receptor B chain-specific immunotoxin

Transplantation 50(1): 1-7

Cavazzana-Calvo M, Stephan JL, Sarnacki S, Chevret S, Fromont C, de Coene

C, Le Deist F, Guy-Grand D, Fischer A 1994 Attenuation of graft-versus-host

disease and graft rejection by ex vivo immunotoxin elimination of alloreactive T cells

in an H-2 haplotype disparate mouse combination Blood 83(1): 288-298

Cederbom L, Hall H and Ivars F 2000 CD4+CD25+ regulatory T cells

down-regulate co-stimulatory molecules on antigen-presenting cells Eur J Immunol 30:

1538 –1543

Ceredig R, Lowenthal JW, Nabholz M, Macdonald HR 1985 Expression of

interleukin-2 receptors as a differentiation marker on intrathymic stem cells Nature

314: 98-101

Chadwick DE, Williams DP, Niho Y, Murphy JR Minden MD 1993

Cytotoxicity of a recombinant diphtheria toxin-granulocyte colony- stimulating factor

fusion protein on human leukemic blast cells Leuk Lymphoma 11: 249

Chan CH, Blazar BR, Eide CR, Kreitman RJ, Vallera DA 1995 A murine

cytokine fusion toxin specifically targeting the murine granulocyte-macrophage colony-stimulating factor (GM-CSF) receptor on normal committed bone marrow

progenitor cells and GM-CSF-dependent tumor cells Blood 86, 2732

Chao NJ, Schlegel PG 1995 Prevention and treatment of graft-versus-host disease

Ann N Y Acad Sci 770: 130-140

Chaudhary VK, Gallo MG, FitzGerald DJ, Pastan I 1990 A recombinant

single-chain immunotoxin composed of anti-Tac variable regions and a truncated diphtheria

toxin Proc Natl Acad Sci U.S.A 87, 9491

Chaudhary VK, Queen C, Junghans RP, Waldmann TA, FitzGerald DJ, Pastan

I 1989 A recombinant immunotoxin consisting of two antibody variable domains

fused to Pseudomonas exotoxin Nature 339: 394-397

Chen BJ, Cui X, Liu C and Chao NJ 2002 Prevention of graft-versus-host disease

while preserving graft-versus-leukemia effect after selective depletion of host-reactive

T cells by photodynamic cell purging process Blood 99: 3083-3088

Cohen JL, Trenado A, Vasey D, Klatzmann D, Salomon BL 2002 CD4+CD25+

Immunoregulatory T cells: New therapeutics for Graft-vs-host disease J Exp Med

196: 401-406

Cohen JL, Trenado A, Vasey D, Klatzmann D, Salomon BL 2002

CD4(+)CD25(+) immunoregulatory T Cells: new therapeutics for graft-versus-host

disease J Exp Med 196(3): 401-406

Cook DN, Beck MA, Coffman TM, Kirby SL, Sheridan JF, Pragnell IB, Smithies

O 1995 Requirement of MIP-1 alpha for an inflammatory response to viral infection

Dailey MO 1998 Expression of T lymphocyte adhesion molecules: regulation during

antigen-induced T cell activation and differentiation Crit Rev Immunol 18(3):

153-184

Dao T, Ohashi K, Kayano T, Kurimoto M, Okamura H 1996

Interferon inducing factor, a novel cytokine, enhances Fas ligand-mediated cytotoxicity of

murine T helper 1 cells Cell Immunol 173: 230–235

De Gast GC, Gratama JW, Ringden O, Gluckman E 1987 The multifactorial

etiology of graft-versus-host disease Immunology Today 8: 209-212

De la Hera A, Toribio ML, Marquez C, Marcos MA, Cabrero E, Martinez-A C

1986 Differentiation of human mature thymocytes: existence of a T3+4-8-

intermediate stage.Eur J Immunol 16(6): 653-658

Delmonte L, O'Reilly RJ, Kirkpatrick D, Kapoor N 1982 In vitro model for

detection of alloreactivity between HLA-matched donor-host pairs Preliminary

evaluation as a predictor of graft-versus-host disease Transplantation 34(2):

100-103

Devos R, Plaetinck G, Cheroutre H, Simons G, Degrave W, Tavernier J, Remaut

E, Fiers W 1983 Molecular cloning of human interleukin 2 cDNA and its expression

in E coli Nucleic Acids Res 11(13): 4307-4323

Dey BR, Yang YG, Szot GL, Pearson DA, Sykes M 1998 Interleukin-12 inhibits

graft-versus-host disease through an Fas-mediated mechanism associated with

alterations in donor T-cell activation and expansion Blood 91(9): 3315-3322

Dickinson AM, Sviland L, Dunn J, Carey P, Proctor SJ 1991 Demonstration of

direct involvement of cytokines in graft-versus-host reactions using an in vitro human

skin explant model Bone Marrow Transplant 7(3): 209-216

Dickinson AM, Sviland L, Hamilton PJ, Usher P, Taylor P, Jackson G, Dunn J, Proctor SJ 1994 Cytokine involvement in predicting clinical graft-versus-host

disease in allogeneic bone marrow transplant recipients Bone Marrow Transplant

13(1): 65-70

Dieckmann D, Bruett CH, Ploettner H, Lutz MB, Schuler G 2002 Human

CD4+CD25+ regulatory, contact-dependent T cells induce interleukin 10-producing,

contact-independent type 1-like regulatory T cells J Exp Med 196: 247 –253

Dieckmann D, Plottner H, Berchtold S, Berger T, Schuler G 2001 Ex vivo

isolation and characterization of CD4+CD25+ T cells with regulatory properties from

human blood J Exp Med 193: 1303 –1310

Dietrich PY, Caignard A, Lim A, Chung V, Pico JL, Pannetier C, Kourilsky P, Hercend T, Even J, Triebel F 1994 In vivo T-cell clonal amplification at time of

acute graft-versus-host disease Blood 84(8): 2815-2820

Dunbar PR, Smith CL, Chao D, Salio M, Shepherd D, Mirza F, Lipp M, Lanzavecchia A, Sallusto F, Evans A, Russell-Jones R, Harris AL, Cerundolo V

2000 A shift in the phenotype of melan-A-specific CTL identifies melanoma patients with an active tumor-specific immune response. J Immunol 165(11): 6644-6652

Dunon D, Piali L, Imhof BA 1996 To stick or not to stick: the new leukocyte

homing paradigm Curr Opin Cell Biol 8(5): 714-723

Ebert LM and McColl SR 2001 Coregulation of CXC chemokine receptor and

CD4 expression on T lymphocytes during allogeneic activation J Immunol 166:

4870-4878

Engelhard D, Nagler A, Singer R, Barak V 1994 Soluble interleukin-2 receptor

levels in cytomegalovirus disease and graft versus host disease after T-lymphocyte depleted bone marrow transplantation for hematological neoplasias Leuk Lymphoma

12(3-4): 273-280

Ermann J, Szanya V, Ford GS, Paragas V, Fathman CG, Lejon K 2001

CD4+CD25+ T cells facilitate the induction of T cell anergy J Immunol 167: 4271 –

4275

Farrar JJ, Benjamin WR, Hilfiker ML, Howard M, Farrar WL, Fuller-Farrar J

1982 The biochemistry, biology, and role of interleukin 2 in the induction of

cytotoxic T cell and antibody-forming B cell responses.Immunol Rev 63: 129-166

Fehse B, Goldmann M, Frerk O, Bulduk M, Zander AR 2000 Depletion of

alloreactive donor T cells using immunomagnetic cell selection Bone Marrow

Transplant 2: S39-42

Fehse B, Frerk O, Goldmann M, Bulduk M, Zander AR 2000b Efficient

depletion of alloreactive donor T lymphocytes based on expression of two

activation-induced antigens (CD25 and CD69) Br J Haematol 109: 644-651

Ferrara JL and Deeg HJ 1991 Graft-versus-host disease N Engl J Med 324:

Ford WL, Simmonds SJ and Atkins RC 1975 Early cellular events in a systemic

graft-vs.-host reaction II Autoradiographic estimates of the frequency of donor

lymphocytes which respond to each Ag-B-determined antigenic complex J Exp

Freitas AA and Rocha BB 1993 Lymphocyte lifespans: homeostasis, selection and

competition Immunol Today 14(1): 25-29

Fujimori Y, Takatsuka H, Takemoto Y, Hara H, Okamura H, Nakanishi K, Kakishita E 2000 Elevated interleukin (IL)-18 levels during acute graft-versus-host

disease after allogeneic bone marrow transplantation Br J Haematol 109(3):

652-657

Fujimori Y, Yoshimoto T, Matsui K, Tsutsui H, Okamoto T, Kashiwamura S, Hada T, Okamura H, Kakishita E, Hara H, Nakanishi K 2002 Increased

expression of interleukin-18 receptor on T lymphocytes in patients with acute versus-host disease after allogeneic bone marrow transplantation

graft-J Interferon Cytokine Res 22(7): 751-754

Fussell ST, Donnellan M, Cooley MA, Farrell C 1994 Cytotoxic T lymphocyte

precursor frequency does not correlate with either the incidence or severity of versus-host disease after matched unrelated donor bone marrow transplantation

from peripheral blood mononuclear cell preparations Transplantation 67: 124-130

Garlisi CG, Pennline KJ, Smith SR, Siegel MI, Umland SP 1993 Cytokine gene

expression in mice undergoing chronic graft-versus-host disease Mol Immunol 30(7):

669-677

Garside P, Reid S, Steel M, Mowat AM 1994 Differential cytokine production

associated with distinct phases of murine graft-versus-host reaction Immunology

Ghayur T, Seemayer TA, Lapp WS 1987 Kinetics of natural killer cell

cytotoxicity during the graft-versus-host reaction Relationship between natural killer cell activity, T and B cell activity, and development of histopathological alterations

Transplantation 44(2): 254-260

Gillis S, Ferm MM, Ou W, Smith KA 1978 T cell growth factor: parameters of

production and a quantitative microassay for activity.J Immunol 120(6): 2027-2032

Goldsmith MA and Greene WC 1994 Interleukin-2 and the interleukin-2 receptor

In: Thomson A (ed.) The Cytokine Handbook (second edition) Pp 58-80 Academic Press, London

Gorczynski RM, Cohen Z, Fu XM, Hua Z, Sun Y, Chen Z 1996 Interleukin-13,

in combination with anti-interleukin-12, increases graft prolongation after portal venous immunization with cultured allogeneic bone marrow-derived dendritic cells

lympholysis assay Evaluation of its clinical value Transplantation 48:559-563

Graca L, Thompson S, Lin C-Y, Adams E, Cobbold SP, Waldmann H 2002

Both CD4 +CD25+ and CD4+CD25- regulatory cells mediate dominant

transplantation tolerance J Immunol 168: 5558 –5565

histocompatibility complex molecules stimulate responses to self peptides Proc Natl Acad Sci U S A 89(7): 2794-2798

Green EA, Choi Y and Flavell RA 2002 Pancreatic lymph node-derived

CD4+CD25+ Treg cells: highly potent regulators of diabetes that require

TRANCE-RANK signals Immunity 16: 183 –191

Gregori S, Casorati M, Amuchastegui S, Smiroldo S, Davalli AM, Adorini L

2001 Regulatory T cells induced by 1α,25-dihydroxyvitamin D3 and mycophenolate

mofetil treatment mediate transplantation tolerance J Immunol 167: 1945 –1953

Grone HJ, Weber C, Weber KS, Grone EF, Rabelink T, Klier CM, Wells TN, Proudfood AE, Schlondorff D, Nelson PJ 1999 Met-RANTES reduces vascular

and tubular damage during acute renal transplant rejection: Blocking monocyte arrest

and recruitment FASEB J 13: 1371-1383

Gu Y, Kuida K, Tsutsui H, Ku G, Hsiao K, Fleming MA, Hayashi N, Higashino

K, Okamura H, Nakanishi K 1997 Activation of interferon- inducing factor

mediated by interleukin-1ß converting enzyme Science 275: 206

Gullberg M and Smith KA 1986 Regulation of T cell autocrine growth T4+ cells

become refractory to interleukin 2 J Exp Med 163(2): 270-284

Gunn MD, Tangemann K, Tam C, Cyster JG, Rosen SD, Williams LT 1998 A

chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes.Proc Natl Acad Sci U S A 95(1): 258-263

Guy-Grand D and Vassalli P 1987 Gut injury in mouse graft-versus-host reaction

(GVHR) Adv Exp Med Biol 216A: 661-671

Habu S, Okumura K, Diamantstein T, Shevach EM 1985 Expression of

interleukin 2 receptor on murine fetal thymocytes Eur J Immunol 15(5): 456-460

Hahn HJ, Kuttler B, Dunger A, Kloting I, Lucke S, Volk HD, von Baehr R, Diamantstein T 1987 Prolongation of rat pancreatic islet allograft survival by

treatment of recipient rats with monoclonal anti-interleukin-2 receptor antibody and cyclosporin.Diabetologia 30(1): 44-46

Hakim FT, Fowler DH, Shearer GM, Gress RE 1998 Animal models of acute and

chronic graft-versus-host disease Current Protocols in Immunology S27:

4.3.1-4.3.21

Hakim FT, Payne S, Shearer GM 1994 Recovery of T cell populations after acute

graft-vs-host reaction J Immunol 152(1): 58-64

Hall BM, Pearce NW, Gurley KE, Dorsch SE 1990 Specific unresponsiveness in

rats with prolonged cardiac allograft survival after treatment with cyclosporine III Further characterization of the CD4+ suppressor cell and its mechanisms of action

J Exp Med 171(1): 141-157

Hall BM 1991 Cells mediating allograft rejection Transplantation 51: 1141-1151

Hancock WW, Gao W, Faia KL, Csizmadia V 2000a Chemokines and their

receptors in allograft rejection.Curr Opin Immunol 12(5): 511-516

Hancock WW, Lu B, Gao W, Csizmadia V, Faia K, King JA, Smiley ST, Ling M,

acute allograft rejection.J Exp Med 192(10): 1515-1520

Hara M, Kingsley CI, Niimi M, Read S, Turvey SE, Bushell AR, Morris PJ, Powrie F, Wood KJ 2001 IL-10 is required for regulatory T cells to mediate

tolerance to alloantigens in vivo J Immunol 166(6):3789-96

Harris DT, Sakiestewa D, Lyons C, Kreitman RJ, Pastan I 1999 Prevention of

graft-versus-host disease (GVHD) by elimination of recipient-reactive donor T cells

with recombinant toxins that target the interleukin 2 (IL-2) receptor Bone Marrow

Transplant 23: 137-144

Hartwig UF, Robbers M, Wickenhauser C, Huber C 2002 Murine acute

graft-versus-host disease can be prevented by depletion of alloreactive T lymphocytes using

activation-induced cell death Blood 99(8): 3041-3049.

Hasegawa H, Utsunomiya Y, Yasukawa M, Yanagisawa K, Fujita S 1994

Induction of G protein-coupled peptide receptor EBI 1 by human herpesvirus 6 and 7 infection in CD4+ T cells J Virol 68(8): 5326-5329

Hayry P 1989 Mechanisms of rejection Curr Opin Immunol 1: 1230-1235

Heeger PS, Greenspan NS, Kuhlenschmidt S, Dejelo C, Hricik DE, Schulak JA, Tary-Lehmann M 1999 Pretransplant frequency of donor-specific, IFN-gamma-

producing lymphocytes is a manifestation of immunologic memory and correlates with the risk of posttransplant rejection episodes J Immunol 163(4): 2267-2275

Heinzel FP, Schoenhaut DS, Rerko RM, Rosser LE, Gately MK 1993

Recombinant interleukin 12 cures mice infected with Leishmania major J Exp Med

177(5): 1505-1509

Hoffmann P, Ermann J, Edinger M, Fathman CG, Strober S 2002 Donor-type

CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease

after allogeneic bone marrow transplantation J Exp Med 196(3): 389-399

Holda JH, Maier T and Claman HN 1990 IL-3, IL-4, and IL-6 enhance

IFN-gamma-dependent bone marrow natural suppressor activity Cell Immunol 125(2):

459-468

Hori S, Nomura T and Sakaguchi S 2003 Control of regulatory T cell development

by the transcription factor FOXP3 Science 1057 –1061

Howard M, Matis L, Malek TR, Shevach E, Kell W, Cohen D, Nakanishi K, Paul

WE 1983 Interleukin 2 induces antigen-reactive T cell lines to secrete BCGF-I. J Exp Med 158(6): 2024-2039

Hsieh CS, Macatonia SE, Tripp CS, Wolf SF, O'Garra A, Murphy KM 1993

Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced

macrophages Science 260(5107): 547-549

Hu H, Dong Y, Feng P, Fechner J, Hamawy M, Knechtle SJ 2003 Effect of

immunosuppressants on T-cell subsets observed in vivo using carboxy-fluorescein diacetate succinimidyl ester labeling Transplantation 75: 1075-1077

Hu H, Robertus M, de Jonge N, Gmelig-Meyling FH, van der Meulen A, Schuurman HJ, Doornewaard H, van Prooijen HC, de Weger RA 1994

Reduction of donor-specific cytotoxic T lymphocyte precursors in peripheral blood of

allografted heart recipients Transplantation 58: 1263-1268

Hu HZ, de Jonge N, Doornewaard H, Gmelig-Meyling FH, Tilanus MG, Bosboom K, Robertus M, Plomp S, van Reijsen FC, Laphor JR, Schuurman HJ, Deweger RA 1994 Cytotoxic T lymphocytes infiltrating the human cardiac allograft

show a restriction in T-cell receptor V beta gene usage: a study on serial biopsy and

blood specimens J Heart Lung Transplant 13: 1058-1071

Hu H, Stavrou S, Cairns Baker B, Tornatore C, Scharff J, Okunieff P, Neville

DM Jr 1997 Depletion of T lymphocytes with immunotoxin retards the progress of

experimental allergic encephalomyelitis in rhesus monkeys Cell Immunol 177(1):

26-34

Hu HZ, Li GL, Lim YK, Chan SH, Yap EH 1999 Kinetics of interferon-γ secretion and its regulatory factors in the early phase of acute graft-versus-host

disease Immunology 98: 379-385

Hu HZ, New JY, Li B, Chan SH, Yap EH 2000 Depletion of activated alloreactive

T cells in prevention of acute graft-versus-host disease Transplant Proc 32:

2456-2457

Itoh M, Takahashi T, Sakaguchi N, Kuniyasu Y, Shimizu J, Otsuka F, Sakaguchi

S 1999 Thymus and autoimmunity: production of CD25+CD4+ naturally anergic

and suppressive T cells as a key function of the thymus in maintaining immunologic

Jacobson LO, Simmons EL, Marks EK, Eldredge JH 1951 Recovery from

radiation injury Science 113(2940): 510-511

Jean LF and Murphy JR.1991 Diphtheria toxin receptor-binding domain

substitution with interleukin 6: Genetic construction and interleukin 6

receptor-specific action of a diphtheria toxin-related interleukin 6 fusion protein Protein Eng

4: 989

Jelinek DF and Lipsky PE 1987 Regulation of human B lymphocyte activation,

proliferation, and differentiation.Adv Immunol 40: 1-59

Johnsen HE, Beatty PG, Michelson E, Hansen JA, Thomas ED 1992a Donor

alloreactivity may predict acute graft-versus-host disease in HLA-matched bone marrow transplantation for leukemia in early remission Eur J Haematol 48(5): 249-

253

Johnsen HE, Bostrom L, Moller J, Jorgensen JA, Jensen L, Ringden O 1992b A

study of donor alloreactivity, which may predict acute graft-versus-host disease in HLA identical bone marrow transplantations for early leukaemia Scand J Immunol

35(3): 353-360

Johnsen HE, Mickelson E, Beatty PG, Hansen JA 1992c Donor alloreactivity may

predict acute graft-versus-host disease in patients receiving marrow transplants from HLA identical siblings.Bone Marrow Transplant 9(2): 91-96

Jones G 1973 The number of reactive cells in mouse lymphocyte cultures stimulated

by PHA, Con A or histocompatibility antigen J Immunol 111: 914-920

Jones MS, Riley R, Hamilton BL, Paupe J, Perez D, Levy RB 1994 Endogenous

superantigens in allogeneic bone marrow transplant recipients rapidly and selectively expand donor T cells which can produce IFN-gamma Bone Marrow Transplant

14(5): 725-735

Jonuleit H, Schmitt E, Kakirman H, Stassen M, Knop J, Enk AH 2002

Infectious tolerance: human CD25+ regulatory T cells convey suppressor activity to

conventional CD4+ T helper cells J Exp Med 196: 255 –260

Jonuleit H, Schmitt E, Schuler G, Knop J, Enk AH 2000 Induction of interleukin

10-producing, non-proliferating CD4+ T cells with regulatory properties by repetitive

stimulation with allogeneic immature human dendritic cells J Exp Med 192: 1213 –

1222

Jonuleit H, Schmitt E, Stassen M, Tuettenberg A, Knop J, Enk AH 2001

Identification and functional characterization of human CD4+CD25+ T cells with

regulatory properties isolated from peripheral blood J Exp Med 193: 1285 –1294

Joshua T and Rubin MD 1995 Interleukin-2: Its rationale and role in the treatment

of patients with cancer In: Kurzrock R (ed.) Cytokine: Interleukins and their Receptors Pp 83-105 Kluwer Academic Publishers

Kalifa C, Hartmann O, Demeocq F, Vassal G, Couanet D, Terrier-Lacombe MJ, Valteau D, Brugieres L, Lemerle J 1992 High-dose busulfan and thiotepa with

autologous bone marrow transplantation in childhood malignant brain tumors: a phase

II study Bone Marrow Transplant 9(4): 227-233

Kaminski E, Hows J, Man S, Brookes P, Mackinnon S, Hughes T, Avakian O, Goldman JM, Batchelor JR 1989 Prediction of graft versus host disease by

frequency analysis of cytotoxic T cells after unrelated donor bone marrow transplantation.Transplantation 48(4): 608-613

Kaminski E, Sharrock C, Hows J, Ritter M, Arthur C, McKinnon S, Batchelor

JR 1988 Frequency analysis of cytotoxic T lymphocyte precursors possible

relevance to HLA-matched unrelated donor bone marrow transplantation Bone Marrow Transplant 3(2): 149-155

Kapoor A, Morita K, Engeman TM, Koga S, Vapnek EM, Hobart MG, Fairchild

RL 2000 Early expression of interferon-gamma inducible protein 10 and monokine

induced by interferon-gamma in cardiac allografts is mediated by CD8+ T cells

Keever CA, Leong N, Cunningham I, Copelan EA, Avalos BR, Klein J, Kapoor

N, Adams PW, Orosz CG, Tutschka PJ 1994 HLA-B44-directed cytotoxic T cells

associated with acute graft-versus-host disease following unrelated bone marrow transplantation.Bone Marrow Transplant 14(1): 137-145

Kennedy MJ, Vogelsang GB, Jones RJ, Farmer ER, Hess AD, Altomonte V, Huelskamp AM, Davidson NE 1994 Phase I trial of interferon gamma to potentiate

cyclosporine-induced graft-versus-host disease in women undergoing autologous

bone marrow transplantation for breast cancer J Clin Oncol 12(2): 249-257

Kernan NA 1994 T-cell depletion for prevention of graft-versus-host disease In:

Forman SJ, Blume KG, Thomas ED, eds Bone Marrow Transplantation Boston, MA: Blackwell;124-135

Kingsley CI, Karim M, Bushell AR, Wood KJ 2002 CD25+CD4+ regulatory T

cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of

alloresponses J Immunol 168: 1080 –1086

Kirkman RL, Barrett LV, Gaulton GN, Kelley VE, Ythier A, Strom TB 1985

Administration of an anti-interleukin 2 receptor monoclonal antibody prolongs cardiac allograft survival in mice J Exp Med 162(1): 358-362

Koga S, Auerbach MB, Engeman TM, Novick AC, Toma H, Fairchild RL 1999

T cell infiltration into class II MHC-disparate allografts and acute rejection is dependent on the IFN-γ-induced chemokine Mig J Immunol 163: 4878-4885

Koh MB, Prentice HG, Corbo M, Morgan M, Cotter FE, Lowdell MW 2002

Alloantigen-specific T-cell depletion in a major histocompatibility complex fully mismatched murine model provides effective graft-versus-host disease prophylaxis in

the presence of lymphoid engraftment Br J Haematol 118: 108-116

Kondo T, Morita K, Watarai Y, Auerbach MB, Taub DD, Novick AC, Toma H, Fairchild RL 2000 Early increased chemokine expression and production in murine

allogeneic skin grafts is mediated by natural killer cells Transplantation 69(5):

969-977

Korngold R, Sprent J 1987 T cell subsets and graft-versus-host disease

Transplantation 44(3): 335-339

Kuniyasu Y, Takahashi T, Itoh M, Shimizu J, Toda G, Sakaguchi S 2000

Naturally anergic and suppressive CD25(+)CD4(+) T cells as a functionally and

phenotypically distinct immunoregulatory T cell subpopulation Int Immunol 12(8):

1145-1155

Kupiec-Weglinski JW, Diamantstein T, Tilney NL, Strom TB 1986 Therapy with

monoclonal antibody to interleukin 2 receptor spares suppressor T cells and prevents

or reverses acute allograft rejection in rats Proc Natl Acad Sci U S A 83(8):

2624-2627

Lakkis F, Steele A, Pacheco-Silva A, Rubin-Kelley V, Strom TB, Murphy JR

1991 Interleukin 4 receptor targeted cytotoxicity: Genetic construction and in vivo

immunosuppressive activity of a diphtheria toxin-related murine interleukin 4 fusion

protein Eur J Immunol 21: 2253

Lambert P, Falmagne P, Capiau C, Zanen J, Ruysschaert JM, Dirkx J 1980

Primary structure of diphtheria toxin fragment B: Structural similarities with lipid

binding domains J Cell Biol 87: 837

Lan FS, Zeng DF, Higuchi M, Huie P, Higgins JP, Strober S 2001 Predominance

of NK1.1 TCR or DX5 TCR T Cells in Mice Conditioned with Fractionated Lymphoid Irradiation Protects Against Graft-Versus-Host Disease: "Natural

Suppressor" Cells J Immunol 167: 2087 - 2096

Leonard JP, Waldburger KE, Goldman SJ 1995 Prevention of experimental

autoimmune encephalomyelitis by antibodies against interleukin 12 J Exp Med

181(1): 381-386

Levings MK, Sangregorio R and Roncarolo M-G 2001 Human CD25+CD4+ T

regulatory cells suppress naive and memory T cell proliferation and can be expanded

in vitro without loss of function J Exp Med 193: 1295 –1301

Levings MK, Sangregorio R and Sartirana C 2002 Human CD25+ CD4+ T

suppressor cell clones produce transforming growth factor b, but not interleukin 10,

and are distinct from type 1 T regulatory cells J Exp Med 196: 1335 –1346

Li B, New JY, Yap EH, Lu JH, Chan SH, Hu HZ 2001.Blocking L-selectin and

α4-integrin changes donor cell homing pattern and ameliorates murine acute graft

versus host disease Eur J Immunol 31: 617-624

Li XC, Demirci G, Ferrari-Lacraz S, Groves C, Coyle A, Malek TR, Strom TB

2001 IL-15 and IL-2: a matter of life and death for T cells in vivo Nat Med 7:

114-118

Liu Z, Geboes K and Hellings P 2001 B7 interactions with CD28 and CTLA-4

control tolerance or induction of mucosal inflammation in chronic experimental

colitis J Immunol 167: 1830 –1838

Lloyd AR, Oppenheim JJ, Kelvin DJ, Taub DD 1996 Chemokines regulate T cell

adherence to recombinant adhesion molecules and extracellular matrix proteins

J Immunol 156(3):932-938

Lochner M and Forster I 2002-2003 Anti-interleukin-18 therapy in murine models

of inflammatory bowel disease Pathobiology 70(3): 164-169 Review

Loetscher M, Gerber B, Loetscher P, Jones SA, Piali L, Clark-Lewis I, Baggiolini

M, Moser B 1996a Chemokine receptor specific for IP10 and mig: structure,

function, and expression in activated T-lymphocytes J Exp Med 184(3): 963-969